ESMO: A Tale Of Two CDK 4/6 Inhibitors With monarchE Success and Failure For PALLAS

Boost For Lilly, Blow For Pfizer

 
• By Alexandra Shimmings
Doctor with Mammography - Image
• Source: Shutterstock

More from Clinical Trials

More from R&D